drugset / Trial / NCT02199561

Fecal Microbiota Transplantation (FMT) in the Management of Active Crohn's Disease

NCT02199561

Phase 1/2 Completed 3 enrolled University of Alberta
NaSingle-groupOpen-labelTreatment

Summary

Manipulation of the intestinal microbiota through FMT is a potential therapeutic target for CD patients. Studies are now required to determine if repeated FMT can overcome the apparent immune response to FMT thereby maintaining sustained clinical improvement and remission. Prior to a large randomized controlled trial of FMT in CD we will carry out a feasibility study to determine if serial FMTs can sustain a clinical response and maintain stability of transplanted microbiota.

Timeline

Start
2014-07
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal Microbiota Transplant Other / unclassified Other

Indications